MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Vacuum-assisted Biopsy Devices by Type (9-12G, Below 9G, Above 12G), by Application (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
The global vacuum-assisted biopsy devices market, valued at $946.5 million in 2025, is projected to experience robust growth, driven by several key factors. The increasing prevalence of various cancers, coupled with the rising demand for minimally invasive diagnostic procedures, fuels market expansion. Technological advancements leading to improved device accuracy, reduced procedural pain, and faster recovery times are further stimulating adoption. The growing geriatric population, susceptible to a higher incidence of cancers requiring biopsies, also contributes significantly to market growth. Furthermore, the rising number of well-equipped hospitals and diagnostic centers, especially in developing economies, provides a fertile ground for market expansion. The segment focusing on 9-12G devices currently holds the largest market share, owing to their widespread application in various biopsy procedures. Hospitals constitute the largest end-user segment, driven by their increased investment in advanced medical technologies. Key players like BD, Mammotome, and Hologic are leveraging technological innovations and strategic partnerships to maintain a competitive edge in this rapidly evolving market.
Vacuum-assisted Biopsy Devices Market Size (In Million)
1.5B
1.0B
500.0M
0
946.5 M
2025
999.7 M
2026
1.056 B
2027
1.116 B
2028
1.179 B
2029
1.245 B
2030
1.315 B
2031
The market's Compound Annual Growth Rate (CAGR) of 5.4% indicates a steady expansion trajectory throughout the forecast period (2025-2033). However, certain restraining factors must be considered. These include the relatively high cost of devices and procedures, potentially limiting access in resource-constrained settings. Moreover, the presence of alternative biopsy techniques and the risk of complications associated with vacuum-assisted biopsies can influence market growth. Despite these limitations, the continuous development of advanced vacuum-assisted biopsy devices with enhanced features, alongside growing healthcare expenditure and technological advancements, is poised to drive the market's positive momentum in the long term. Geographical expansion, particularly in emerging markets with growing healthcare infrastructure, will play a pivotal role in shaping the market landscape in the coming years. North America and Europe are anticipated to retain significant market share, driven by robust healthcare infrastructure and technological advancements.
Vacuum-assisted Biopsy Devices Company Market Share
Loading chart...
Vacuum-assisted Biopsy Devices Trends
The global vacuum-assisted biopsy devices market is experiencing robust growth, projected to reach multi-million unit sales by 2033. Driven by an aging population, increasing prevalence of breast cancer and other diseases requiring biopsy procedures, and technological advancements leading to minimally invasive and more precise devices, the market shows significant promise. The historical period (2019-2024) witnessed a steady rise in demand, with the estimated year (2025) showcasing a significant surge. This upward trajectory is expected to continue throughout the forecast period (2025-2033). Key market insights reveal a strong preference for less invasive procedures, fueling the demand for smaller gauge needles (below 9G). This trend is coupled with a growing adoption of vacuum-assisted biopsy devices in diagnostic and imaging centers, driven by the need for faster turnaround times and improved patient experience. The market is characterized by the presence of major players like BD, Mammotome, and Hologic, each contributing significantly to innovation and market share. Competition is fierce, however, and companies are focusing on developing devices with enhanced features such as improved image guidance, reduced procedural time, and better tissue acquisition. This leads to better diagnostic accuracy, decreased complications, and enhanced patient outcomes, further stimulating market growth. The study period (2019-2033) will undoubtedly witness further consolidation and innovation within this dynamic sector. The market size in million units, however specific figures are not provided in the prompt, is projected to show a compound annual growth rate (CAGR) reflecting this robust expansion.
Driving Forces: What's Propelling the Vacuum-assisted Biopsy Devices Market?
Several factors are driving the expansion of the vacuum-assisted biopsy devices market. Firstly, the rising global prevalence of breast cancer and other diseases requiring biopsy procedures is a major contributor. Early and accurate diagnosis is crucial for effective treatment, and vacuum-assisted biopsy devices offer a less invasive and more efficient method compared to traditional techniques. Secondly, technological advancements are continually improving the precision, safety, and efficacy of these devices. Smaller gauge needles, improved image guidance systems, and more efficient tissue acquisition mechanisms are all contributing to increased adoption. Thirdly, the increasing preference for minimally invasive procedures among both patients and healthcare providers is a significant driving force. Vacuum-assisted biopsy techniques offer advantages like reduced pain, shorter recovery times, and smaller incisions, making them attractive alternatives to more invasive surgical approaches. Fourthly, the growing number of hospitals, diagnostic imaging centers, and academic research institutes investing in advanced medical technologies fuels the demand for these devices. Finally, favorable reimbursement policies in many regions and increased awareness regarding the benefits of early cancer detection further support the market’s robust growth.
Challenges and Restraints in Vacuum-assisted Biopsy Devices
Despite the significant growth potential, the vacuum-assisted biopsy devices market faces certain challenges and restraints. High initial investment costs associated with purchasing and maintaining these advanced devices can be a barrier for smaller healthcare facilities, particularly in developing countries. Furthermore, the complexity of the procedures and the need for well-trained personnel can limit widespread adoption. Potential complications associated with the procedure, although rare, can create concerns among patients and healthcare providers. Stringent regulatory requirements and approvals processes can also delay market entry for new devices and technologies. Lastly, competition among established players and the emergence of new technologies continually put pressure on pricing and profit margins. Overcoming these challenges requires collaborative efforts between manufacturers, healthcare providers, and regulatory bodies to ensure broader accessibility and continued innovation within the market.
Key Region or Country & Segment to Dominate the Market
The North American market, specifically the United States, is expected to hold a significant share of the global vacuum-assisted biopsy devices market throughout the forecast period. This dominance is attributed to factors such as high healthcare expenditure, advanced medical infrastructure, a large aging population, and high prevalence of breast cancer and other diseases requiring biopsy. Within the segments, the 9-12G needle size is currently the dominant type. However, there is a growing trend toward smaller gauge needles (below 9G) due to their less invasive nature and improved patient comfort. This shift is expected to gain momentum during the forecast period. Hospitals continue to represent the largest application segment due to their established infrastructure and high volume of biopsy procedures. However, the market share of diagnostic and imaging centers is steadily growing due to their increased adoption of minimally invasive techniques and focus on efficient patient care.
North America (United States): High healthcare expenditure, advanced infrastructure, aging population, and high prevalence of relevant diseases.
Europe: Growing awareness of early cancer detection and minimally invasive techniques.
Asia-Pacific: Rapid economic growth, expanding healthcare infrastructure, and increasing prevalence of target diseases are driving market growth in this region. China and India will be key contributors.
9-12G Needle Size: Currently dominant due to established usage and suitability for a wide range of applications.
Below 9G Needle Size: Rapidly growing segment due to minimally invasive nature and increased patient comfort.
Hospitals: Largest application segment due to high volume of procedures and established infrastructure.
Diagnostic and Imaging Centers: Growing segment due to focus on efficiency and patient experience.
Growth Catalysts in Vacuum-assisted Biopsy Devices Industry
Several factors are accelerating growth in the vacuum-assisted biopsy devices industry. The continued development of smaller gauge needles leading to improved patient comfort and reduced complications is a key driver. Simultaneously, advancements in image guidance technologies enhance procedure precision and reduce the risk of complications. Increased investment in research and development by leading manufacturers is also contributing to improved device performance and broader market appeal. Finally, rising healthcare expenditure and growing awareness of early disease detection further stimulate market expansion. These combined elements create a positive feedback loop, accelerating the adoption of vacuum-assisted biopsy devices globally.
Leading Players in the Vacuum-assisted Biopsy Devices Market
This report offers a comprehensive analysis of the vacuum-assisted biopsy devices market, covering historical data (2019-2024), the estimated year (2025), and future projections (2025-2033). It provides detailed insights into market trends, driving forces, challenges, key players, and significant developments. Furthermore, the report segments the market based on device type (needle gauge) and application, offering a granular view of market dynamics. The analysis helps understand the growth drivers, competitive landscape, and potential opportunities for stakeholders within this rapidly expanding sector. The million-unit sales projections provide a clear understanding of the market’s substantial size and potential.
Vacuum-assisted Biopsy Devices Segmentation
1. Type
1.1. 9-12G
1.2. Below 9G
1.3. Above 12G
2. Application
2.1. Hospitals
2.2. Academic and Research Institutes
2.3. Diagnostic and Imaging Centers
Vacuum-assisted Biopsy Devices Segmentation By Geography
Table 91: Rest of Asia Pacific Vacuum-assisted Biopsy Devices Revenue (undefined) Forecast, by Application 2020 & 2033
Table 92: Rest of Asia Pacific Vacuum-assisted Biopsy Devices Volume (K) Forecast, by Application 2020 & 2033
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders
Secondary Research
Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Vacuum-assisted Biopsy Devices?
The projected CAGR is approximately 11.7%.
2. Which companies are prominent players in the Vacuum-assisted Biopsy Devices?
Key companies in the market include BD, Mammotome, Hologic, .
3. What are the main segments of the Vacuum-assisted Biopsy Devices?
The market segments include Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD XXX N/A as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in N/A and volume, measured in K.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Vacuum-assisted Biopsy Devices," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Vacuum-assisted Biopsy Devices report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Vacuum-assisted Biopsy Devices?
To stay informed about further developments, trends, and reports in the Vacuum-assisted Biopsy Devices, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Vacuum-assisted Biopsy Devices